Showing results (181-190 of 198) with videos related to
Sort By:
Pageof 20
Experimental & Molecular Medicine|August 6, 2016
Targeted exome sequencing resolves allelic and the genetic heterogeneity in the genetic diagnosis of nephronophthisis-related ciliopathyHee Gyung Kang, Hyun Kyung Lee, Yo Han Ahn, et al.JBMR Plus|May 1, 2024
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension periodLeanne M Ward, Wolfgang Högler, Francis H Glorieux, et al.The Journal of Clinical Endocrinology and Metabolism|April 21, 2023
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose LevelErik A Imel, Francis H Glorieux, Michael P Whyte, et al.Pediatric Nephrology (Berlin, Germany)|September 5, 2020
Lower albumin level and longer disease duration are risk factors of acute kidney injury in hospitalized children with nephrotic syndromeEun Mi Yang, Kee Hwan Yoo, Yo Han Ahn, et al.Journal of the American Society of Nephrology : JASN|May 21, 2017
The Phenotypic Spectrum of Nephropathies Associated with Mutations in Diacylglycerol Kinase εKarolis Azukaitis, Eva Simkova, Mohammad Abdul Majid, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 28, 2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary AnalysisKarl L Insogna, Karine Briot, Erik A Imel, et al.Calcified Tissue International|January 23, 2021
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked HypophosphatemiaRaja Padidela, Michael P Whyte, Francis H Glorieux, et al.Lancet (London, England)|May 21, 2019
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trialErik A Imel, Francis H Glorieux, Michael P Whyte, et al.American Journal of Human Genetics|September 29, 2015
Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic SyndromeNoriko Miyake, Hiroyasu Tsukaguchi, Eriko Koshimizu, et al.Pediatric Nephrology (Berlin, Germany)|January 10, 2024
Development of a tool for predicting HNF1B mutations in children and young adults with congenital anomalies of the kidneys and urinary tractMarcin Kołbuc, Mateusz F Kołek, Rafał Motyka, et al.Pageof 20